×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
BioSpace
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
2 hours ago
Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors
MarketWatch
Shares of Gilead Sciences Inc. dropped 0.56% to $66.93 Wednesday, on what proved to be an all-around poor trading session for the stock...
2 days ago
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo Finance
Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.
1 day ago
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts - Gilead Sciences (NASDAQ:GILD)
Benzinga
In the last three months, 12 analysts have published ratings on Gilead Sciences. GILD+0.91%. + Free Alerts. , offering a diverse range of...
6 hours ago
Gilead Sciences Reports 13.9% Passive Stake In Leap Therapeutics As Of April 10- SEC Filing
XM
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view...
5 hours ago
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ...
PR Newswire
PRNewswire/ -- Gilead Sciences, Inc. (Nasdaq: GILD), announced a global distribution of US$4 million through its ALL4LIVER Grant ("Grant")...
4 days ago
Gilead Sciences (NASDAQ:GILD) Sets New 52-Week Low on Analyst Downgrade
Defense World
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) hit a new 52-week low during trading on Wednesday after UBS Group lowered their price...
11 hours ago
Zeroing In: Ending the HIV Epidemic | Gilead
Gilead Sciences
Through the Zeroing In program, Gilead has awarded $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance...
7 months ago
Gilead Sciences (NASDAQ:GILD) Stock Rating Reaffirmed by Oppenheimer
MarketBeat
Oppenheimer reissued an "outperform" rating and set a $105.00 target price on shares of Gilead Sciences in a report on Friday.
7 hours ago
Gilead Sciences Inc. stock outperforms competitors despite losses on the day
MarketWatch
Shares of Gilead Sciences Inc. slid 0.65% to $67.31 Tuesday, on what proved to be an all-around mixed trading session for the stock market,...
3 days ago